...
首页> 外文期刊>Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences >Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.
【24h】

Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.

机译:液相色谱-电喷雾串联质谱法测定人血浆中奥美拉唑的高灵敏方法:在临床药代动力学研究中的应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A highly sensitive, rapid assay method has been developed and validated for the estimation of omeprazole (OPZ) in human plasma with liquid chromatography coupled to tandem mass spectrometry with electrospray ionization in the positive-ion mode. The assay procedure involves alkalinization of plasma followed by simple liquid-liquid extraction of OPZ and lansoprazole (internal standard, IS) from human plasma with acetonitrile. Chromatographic separation was achieved with 0.01 M ammonium acetate:acetonitrile (40:60, v/v) at a flow rate of 0.25 mL/min on an Inertsil ODS 3 column with a total run time 2.5 min. The MS/MS ion transitions monitored were 346.1 --> 198.1 for OPZ and 370.1 --> 252.1 for IS. Method validation and clinical sample analysis were performed as per FDA guidelines and the results met the acceptance criteria. The lower limit of quantitation achieved was 0.05 ng/mL and the linearity was observed from 0.05 to 10.0 ng/mL. The intra-day and inter-day precisions were in the ranges 2.09-8.56 and 5.29-8.19%, respectively. This novel method has been applied to a pharmacokinetic study of OPZ in humans.
机译:已开发出一种高灵敏度,快速的测定方法,并已通过液相色谱与串联质谱联用电喷雾电离以正离子模式联用,对人血浆中的奥美拉唑(OPZ)进行了估算。测定步骤包括血浆的碱化,然后用乙腈从人血浆中简单地液-液萃取OPZ和兰索拉唑(内标,IS)。在Inertsil ODS 3色谱柱上以0.01 mL / min的流速用0.01 M乙酸铵:乙腈(40:60,v / v)进行色谱分离,总运行时间为2.5 min。监测到的MS / MS离子跃迁对于OPZ为346.1-> 198.1,对于IS为370.1-> 252.1。按照FDA指南进行方法验证和临床样品分析,结果符合接受标准。达到的定量下限为0.05 ng / mL,从0.05到10.0 ng / mL观察到线性。日内和日间精度分别在2.09-8.56和5.29-8.19%的范围内。该新方法已被应用于人体中OPZ的药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号